Association of Insulin Resistance with Hyperandrogenia in Women

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Hormone Research in Paediatrics

• Publication date

  2001-09-28

• Fields of study

  Medicine

• Identifiers
  DOI 10.1159/000053281PMID 11595827
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Insulin Resistance, Polycystic Ovary Syndrome and Metformin

  2012cited by this paper
• The genetic basis of polycystic ovary syndrome.

  2002cited by this paper
• Diabète des femmes à barbe: a classic paper reread.

  2000cited by this paper
• The Second International Symposium on the Developmental Aspects of Androgen Excess, Toronto, Canada, 20 June 2000.

  2000cited by this paper
• Signaling pathways in insulin action: molecular targets of insulin resistance.

  2000cited by this paper
• Insulin sensitivity, insulin secretion, and metabolic and hormonal parameters in healthy women and women with polycystic ovarian syndrome.

  2000cited by this paper
• Dysregulation of IRS-proteins causes insulin resistance and diabetes

  2000cited by this paper
• Androgen receptor-mediated hypersensitivity to androgens in women with nonhyperandrogenic hirsutism: skewing of X-chromosome inactivation.

  1999cited by this paper
• Signaling Mechanisms That Regulate Glucose Transport*

  1999cited by this paper
• Thirty-seven candidate genes for polycystic ovary syndrome: strongest evidence for linkage is with follistatin.

  1999cited by this paper
• Lean Women With Polycystic Ovary Syndrome Respond to Insulin Reduction With Decreases in Ovarian P450c17 alpha Activity and Serum Androgens

  1998cited by this paper
• Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome.

  1998cited by this paper
• Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome.

  1998cited by this paper
• 17α-Hydroxyprogesterone Responses to Leuprolide and Serum Androgens in Obese Women with and without Polycystic Ovary Syndrome after Dietary Weight Loss1

  1997cited by this paper
• Lean women with polycystic ovary syndrome respond to insulin reduction with decreases in ovarian P450c17 alpha activity and serum androgens.

  1997cited by this paper
• 17 alpha-Hydroxyprogesterone responses to leuprolide and serum androgens in obese women with and without polycystic ovary syndrome offer dietary weight loss.

  1997cited by this paper
• The genetic basis of polycystic ovary syndrome.

  1997cited by this paper
• Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis.

  1997cited by this paper
• POLYCYSTIC OVARY SYNDROME : APPROACHING THE MILLENNIUM

  1997cited by this paper
• Dyslipidaemia is associated with insulin resistance in women with polycystic ovaries

  1996cited by this paper
• Polycystic ovary syndrome.

  1995cited by this paper
• Pharmacokinetics of 2-ethyl-1,3-hexanediol. III. In vitro skin penetration comparisons using the excised skin of humans, rats, and rabbits.

  1995cited by this paper
• Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome.

  1995cited by this paper
• Potential functions of plasma steroid-binding proteins.

  1995cited by this paper
• Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion.

  1995cited by this paper
• Serine phosphorylation of human P450c17 increases 17,20-lyase activity: implications for adrenarche and the polycystic ovary syndrome.

  1995cited by this paper
• Effects of diet and metformin administration on sex hormone-binding globulin, androgens, and insulin in hirsute and obese women.

  1995cited by this paper
• DHEA and Peripheral Androgen and Estrogen Formation: Intracrinology

  1995cited by this paper
• Hyperandrogenism, insulin resistance and acanthosis nigricans. 10 years of progress.

  1994cited by this paper
• Enhanced early insulin response to glucose in relation to insulin resistance in women with polycystic ovary syndrome and normal glucose tolerance.

  1994cited by this paper
• Defects in beta-cell function in functional ovarian hyperandrogenism.

  1993cited by this paper
• Cellular mechanisms of insulin resistance in polycystic ovarian syndrome

  1993cited by this paper
• Insulin resistance in polycystic ovary syndrome: decreased expression of GLUT-4 glucose transporters in adipocytes.

  1993cited by this paper
• Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome

  1992cited by this paper
• Cellular mechanisms of insulin resistance in polycystic ovarian syndrome.

  1992cited by this paper
• Polycystic ovary syndrome and risk for myocardial infarction: Evaluated from a risk factor model based on a prospective population study of women

  1992cited by this paper
• Pathophysiology of sex hormone binding globulin (SHBG): relation to insulin.

  1991cited by this paper
• The functions of corticosteroid-binding globulin and sex hormone-binding globulin: recent advances.

  1990cited by this paper
• DIET‐INDUCED CHANGES IN SEX HORMONE BINDING GLOBULIN AND FREE TESTOSTERONE IN WOMEN WITH NORMAL OR POLYCYSTIC OVARIES: CORRELATION WITH SERUM INSULIN AND INSULIN‐LIKE GROWTH FACTOR‐I

  1989cited by this paper
• Clinical and hormonal characteristics of obese amenorrheic hyperandrogenic women before and after weight loss.

  1989cited by this paper
• 5α-Reductase Activity in the Genital Skin of Hirsute Women*

  1985cited by this paper
• 5 alpha-Reductase activity in the genital skin of hirsute women.

  1985cited by this paper

• Skin disease related to metabolic syndrome in women☆☆☆

  2019cites this paper
• Gynecologic and andrologic dermatology and the metabolic syndrome.

  2018cites this paper
• Atherogenic index of plasma in non‐obese women with androgenetic alopecia

  2015cites this paper
• Unravelling the link between insulin resistance and androgen excess

  2015cites this paper
• Endocrine Disorders and the Skin

  2011cites this paper
• Androgenetic alopecia and cardiovascular risk factors in men and women: a comparative study.

  2010cites this paper
• Disorders of Hair

  2010cites this paper
• Role of the transcriptional factors FOXO1 and PPARG on gene expression of SLC2A4 in endometrial tissue from women with polycystic ovary syndrome.

  2010cites this paper
• Recent advances in acne vulgaris research: insights and clinical implications.

  2008cites this paper
• Metabolic characteristics of women with polycystic ovaries and oligo‐amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome

  2007cites this paper
• The presence of insulin resistance and comparison of various insulin sensivity indices in women with androgenetic alopecia.

  2007cites this paper
• Hyperreactio luteinalis presenting with marked hyperglycemia and bilateral multicystic adnexal masses at 21 weeks gestation.

  2006cites this paper
• Assessment of Insulin Resistance in the Idiopathic Hirsutism

  2006cites this paper
• Diagnostic criteria for polycystic ovarian syndrome

  2006cites this paper
• Hyperreactio Luteinalis Presenting with Marked Hyperglycemia and Bilateral Multicystic Adnexal Masses at 21 Weeks Gestation

  2006cites this paper
• PCOS according to the Rotterdam consensus criteria: change in prevalence among WHO‐II anovulation and association with metabolic factors

  2006cites this paper
• Biliopancreatic Diversion as a Novel Approach to the HAIR-AN Syndrome

  2005cites this paper
• Changes in ovarian steroidogenesis in insulin-resistant, type 2 diabetic Goto-Kakizaki rats after thyroidectomy and gonadotropin treatment.

  2005cites this paper
• Effect of gonadotropin-releasing-hormone-induced hypogonadism on insulin action as assessed by euglycemic clamp studies in men.

  2005cites this paper
• Prevalence of acanthosis nigricans in newly-diagnosed type 2 diabetes.

  2004cites this paper
• Glucose intolerance in a large cohort of mediterranean women with polycystic ovary syndrome: phenotype and associated factors.

  2004cites this paper
• Effect of gonadotropin-releasing hormone hypogonadism on insulin action as assessed by hyperglycemic clamp studies in men.

  2004cites this paper
• ROLE OF PHYSICAL EXERCISE, FITNESS AND AEROBIC TRAINING IN TYPE 1 DIABETIC AND HEALTHY MEN IN RELATION TO THE LIPID PROFILE, LIPID PEROXIDATION AND THE METABOLIC SYNDROME

  2003cites this paper
• Polycystic ovary syndrome (PCOS), insulin resistance and insulin-like growth factors (IGfs)/IGF-binding proteins (IGFBPs).

  2003cites this paper
• Comparison of various simple insulin sensitivity and beta-cell function indices in lean hyperandrogenemic and normoandrogenemic young hirsute women.

  2003cites this paper
• Plasma viscosity as an early cardiovascular risk factor in hirsute women with eumenorrhea or oligomenorrhea.

  2003cites this paper
• Insulin-lowering agents in the management of polycystic ovary syndrome.

  2003cites this paper
• LAAKSONEN Role of Physical Exercise , Fitness and Aerobic Training in Type I Diabetic and Healthy Men in Relation to the Lipid Profile , Lipid Peroxidation and the Metabolic Syndrome

  2003cites this paper
• The equine metabolic syndrome peripheral Cushing's syndrome.

  2002influential citation
• CYP17 genetic polymorphism in endometrial cancer: are only steroids involved?

  2002cites this paper
• Clinical manifestations and insulin resistance (IR) in polycystic ovary syndrome (PCOS) among South Asians and Caucasians: is there a difference?

  2002cites this paper